Invests in
Stages:
Locations:
Min Investment:
$500,000.00Max Investment:
$15,000,000.00Target Investment:
$7,000,000.00
Education
Work Experience
2020
Chief Executive Officer
2020
2020
CEO partner
2020
2022
Member Board of Directors
2022
2017
Board of Advisors
2017
2020 - 2022
Board of Directors
2020 - 2022
2019 - 2020
SVP, Head of Ophthalmology Franchise
2019 - 2020
2017 - 2019
EVP, Chief Development Officer
2017 - 2019
Nightstar Therapeutics (Acquired by Biogen in June 2019)
2014 - 2017
Chief Medical Officer
2014 - 2017
SVP, Head of Clinical and Research Development (2014-2016)
2010 - 2014
VP, Clinical Development and Operations
2010 - 2014
Executive Director, Head of Clinical and Scientific Affairs (2010 -2013)
2005 - 2010
Global Clinical Lead
2005 - 2010